Tags

Type your tag names separated by a space and hit enter

Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine.
Vaccine. 2006 Apr 05; 24(15):2843-9.V

Abstract

A retrospective review was conducted of yellow fever vaccination among laboratory workers receiving annual serologic assessment to determine the initial and long-term response after boosting. Patients were divided into three groups based on pre-vaccination serology: Group 1, 1:10; Group 2, 1:20-1:40 and Group 3, >1:40. The percent with > or = four-fold increase in titers after booster vaccination were: 78% (646/829, Group 1), 65% (79/121, Group 2) and 10% (8/79, Group 3) (p<0.0001). The median times to titer failure (<1:40) were 798 days (Group 1), 3340 days (Group 2) and 7709 days (Group 3) (p<0.0001). Pre-vaccination serology influenced the initial and long-term response to yellow fever booster vaccination.

Authors+Show Affiliations

Division of Medicine, United States Army Medical Research Institute for Infectious Diseases, 1425 Porter Street, Fort Detrick, MD 21702-5011, USA. matthew.hepburn@amedd.army.milNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

16494976

Citation

Hepburn, M J., et al. "Neutralizing Antibody Response to Booster Vaccination With the 17d Yellow Fever Vaccine." Vaccine, vol. 24, no. 15, 2006, pp. 2843-9.
Hepburn MJ, Kortepeter MG, Pittman PR, et al. Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine. Vaccine. 2006;24(15):2843-9.
Hepburn, M. J., Kortepeter, M. G., Pittman, P. R., Boudreau, E. F., Mangiafico, J. A., Buck, P. A., Norris, S. L., & Anderson, E. L. (2006). Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine. Vaccine, 24(15), 2843-9.
Hepburn MJ, et al. Neutralizing Antibody Response to Booster Vaccination With the 17d Yellow Fever Vaccine. Vaccine. 2006 Apr 5;24(15):2843-9. PubMed PMID: 16494976.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine. AU - Hepburn,M J, AU - Kortepeter,M G, AU - Pittman,P R, AU - Boudreau,E F, AU - Mangiafico,J A, AU - Buck,P A, AU - Norris,S L, AU - Anderson,E L, Y1 - 2006/01/18/ PY - 2005/08/11/received PY - 2005/12/08/revised PY - 2005/12/23/accepted PY - 2006/2/24/pubmed PY - 2006/10/27/medline PY - 2006/2/24/entrez SP - 2843 EP - 9 JF - Vaccine JO - Vaccine VL - 24 IS - 15 N2 - A retrospective review was conducted of yellow fever vaccination among laboratory workers receiving annual serologic assessment to determine the initial and long-term response after boosting. Patients were divided into three groups based on pre-vaccination serology: Group 1, 1:10; Group 2, 1:20-1:40 and Group 3, >1:40. The percent with > or = four-fold increase in titers after booster vaccination were: 78% (646/829, Group 1), 65% (79/121, Group 2) and 10% (8/79, Group 3) (p<0.0001). The median times to titer failure (<1:40) were 798 days (Group 1), 3340 days (Group 2) and 7709 days (Group 3) (p<0.0001). Pre-vaccination serology influenced the initial and long-term response to yellow fever booster vaccination. SN - 0264-410X UR - https://www.unboundmedicine.com/medline/citation/16494976/Neutralizing_antibody_response_to_booster_vaccination_with_the_17d_yellow_fever_vaccine_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0264-410X(06)00018-1 DB - PRIME DP - Unbound Medicine ER -